Baseline patient characteristics across neutralizing monoclonal antibody trials. by Elizabeth S. Munroe (21568166)

Subjects:

Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies. by Elizabeth S. Munroe (21568166)

Subjects:

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... by Elizabeth S. Munroe (21568166)

Subjects:

Overview of the six original ACTIV-3/TICO trials. by Elizabeth S. Munroe (21568166)

Subjects:

Loss of FOXP1 results in decreased number of bRGCs. by Seon Hye E. Park (16765033)

Discrimination performance deteriorated as the safe-to-conditioned ΔF decreased. by Chi Chen (67021)

AMS scores decrease over three days at high-altitude. by Erica C. Heinrich (6832055)

The effects of NAC on the decreased number of myotube formations caused by arecoline. by Yi-Xuan Li (6633845)

Higher baseline PV rates decrease the need for interneuron specialization. by Joram Keijser (12475353)

Damage accumulation decreases elongation rates and displaces growth equilibrium. by Audrey Menegaz Proenca (845486)

“…<p>All panels depict MG1655 wild-type <i>E</i>. <i>coli</i>. (A) Exposure to phototoxic damage led to decreasing elongation rates in all treatment levels (length of exposure, every 2 min: 70 ms, 700 ms, 1 s, 1.5 s, 3 s). …”

PGRN decreased Dectin-2 expression on the surface of macrophages and neutrophils. by Jiayu Liu (3951515)

Over time, melanization decreases with aging, higher temperature, and infection. by Lindsay E. Martin (17377067)

The monoterpene 1,8-cineole decreased parasitemia levels in vitro. by Edgleyson C. dos Santos (12536575)

DHA decreased cell viability in HepG3 cells. by Arlet Hernandez (12289155)

Intratracheal hinokitiol injection decreases bacterial load in BALF and serum. by Toshihito Isono (8587668)

Absence of FumC leads to decreased susceptibility to bactericidal antibiotics. by Stephanie D. Himpsl (8501868)

The protein level of ApoB was decreased in HCV-infected cells. by Bei Wang (116772)

Afatinib decreases MAPK and AKT activation after MET knockdown. by Karolin Ebert (7434713)

<i>B. bassiana</i> decreased longevity and impaired climbing. by Deepanshu N. D. Singh (20721878)

The mean and standard deviation of parameters. by Sadaf Sepasgozar Sarkhosh (20436143)

“…Secondary outcomes included performance, fear of movement, and perceived ankle instability, measured using the side-hop test, the Tampa Scale for Kinesiophobia (TSK), and the Cumberland Ankle Instability Tool (CAIT), respectively. Results indicated a significant decrease in ML SI in both groups one month after treatment compared to before and after treatment (P = 0.013 and P<0.001, respectively). …”